PeptideStack
5.2kquestions
20kanswers
220users

How many freeze-thaw cycles will mazdutide at 10 mg/mL tolerate?

Asked 26 Jun 2025Modified 9 months agoViewed 23k times
33

What I have: mazdutide · 10 mg/mL.

I would like to understand the steps well enough to explain them to someone else.

I have access to a refrigerator with a logger and a freezer without one, which may be relevant.

Concretely, what should I do, and how would I know afterwards whether I did it right?

freeze-thaw
freeze-thaw

What repeated freezing does to a peptide in solution: ice-crystal shear at the growing front, freeze-concentration of solutes, pH shifts as buffer…

57 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

701 questions
mazdutide
mazdutide

A GLP-1 and glucagon receptor dual agonist developed primarily in China, with a distinct dose range and a fast-moving publication record.…

237 questions
shareeditfollowflag
TW
askedtamsin_wray9.9k1626 Jun 2025
Do you know the residual moisture? It predicts this better than any date does. – Dr_Wren_Halliday 10 months ago
add a comment

5 Answers

Accepted answer first, then by votes
84

Accepted answer

Nobody has published a cycle count, and at 10 mg/mL the concentration tells you what a wrong guess costs: a 0.1 mL aliquot holds 1 mg and every microlitre is 10 µg. Damage from freezing is not gradual attrition — it is concentrated at the phase transitions, where ice excludes solute and the unfrozen fraction climbs well above 10 mg/mL for as long as the transition lasts. Two slow cycles can therefore do more than four fast ones, which is why a cycle count is the wrong unit in the first place. The way to make the number one is to make it one: split at reconstitution into single-draw aliquots, label each with 10 mg/mL and the date, and never thaw a container you will refreeze.

Thawing at room temperature rather than in warm water reduces the interfacial stress.

During freezing, solutes are excluded from the ice lattice and concentrate into the residual liquid. Local concentrations can rise many-fold, which promotes aggregation independently of temperature.

Thaw slowly at room temperature or in the refrigerator rather than in warm water. Rapid warming creates local thermal and concentration gradients that promote aggregation.

Cryoconcentration of solutes at the ice front is a well-documented mechanism in freeze-thaw damage to proteins and peptides.

Aliquot before the first freeze. That is the whole answer.

shareimprove this answerflag
FC
answered · acceptedfiadh_cronin58k5824 Sept 2025
Aliquoting before the first freeze is the advice I wish I had read two years ago. – syringe_ninety 7 months ago
8This should be linked from the help pages. – lyoph_cake 6 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
72

Start with how many cycles are actually planned, because one or two are immaterial and ten are not.

The mitigation is aliquoting. Divide the reconstituted solution into single-use volumes before the first freeze, and each aliquot then experiences exactly one cycle.

Never refreeze a thawed aliquot. The whole point of aliquoting is that the aliquot is single-use, and refreezing it discards the benefit.

Aliquoting itself is a handling step and introduces its own contamination opportunity.

Dry powder tolerates cycles far better than solution does.

shareimprove this answerflag
BU
answeredbufferline4230k1385 Oct 2025
38

The honest answer is that people worry about the freezer temperature and should worry about the number of cycles.

Count cycles rather than worrying about degrees. Minus twenty and minus eighty differ far less than one cycle and five do.

Stated carefully, a dry lyophilised powder is much less affected by a temperature cycle because there is no liquid phase for anything to concentrate into. Condensation on a cold vial opened warm is the real risk there.

Selective crystallisation of sodium phosphate buffer components producing large pH shifts on freezing is a classical result in the lyophilisation literature.

Thaw slowly and never refreeze an aliquot.

shareimprove this answerflag
MO
answeredmarta_okonkwo190k25829 Jun 2025
31

The relevant physics is ice-front concentration: as water crystallises, everything dissolved is concentrated into the shrinking liquid phase, including buffer salts.

Let a frozen vial reach room temperature before opening it. Opening a cold vial in humid air condenses water into the cake, which raises residual moisture and undoes what lyophilisation achieved.

Aliquoting to eliminate repeated cycles is standard laboratory practice for exactly this reason.

The number of tolerable cycles is sequence- and formulation-dependent and no general number is honest.

Let a frozen vial reach room temperature before opening, or you condense water into it.

edited 29 Oct 2025 by marta_okonkwo — fixed an arithmetic slip in the third paragraph

shareimprove this answerflag
MO
answeredmarta_okonkwo190k25816 Oct 2025
23

Answering this needs to know whether the material is dry or in solution, since a dry powder is largely indifferent to a temperature cycle.

Buffer salts crystallise at different points during freezing. Sodium phosphate is the classic example: the dibasic form crystallises first and the pH of the residual liquid falls by several units. That pH excursion is the real damage in many cases.

Condensation onto cold lyophilised material on opening is a recognised handling error and is the basis for the equilibrate-before-opening rule.

Count cycles, not degrees. The cycle is the damaging event.

shareimprove this answerflag
BQ
answeredbounty_hunter_q15k1722 Jul 2025
4I have kept vials both ways for a year and this matches what I saw. – Dr_Yusuf_Adeyemi 5 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.